1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

CarrierGene Biotech (Suzhou) Co., Ltd

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2017

Location

Suzhou Jiangsu China

Primary Industry

Biotechnology

About

Established in 2017 and based in Suzhou, China, CarrierGene Biotech (Suzhou) Co., Ltd is a gene detection company that focuses on genetic screening and diagnosis through genetic technology and big data algorithms, providing genetic data analysis and health management recommendations. The company has offices in Houston, Shanghai and Suzhou. In February 2018, the company raised an undisclosed amount in angel funding from new investors. The company passed ISO9001 and ISO13485 quality management system certification. The clinical product line of CarrierGene Biotech is mainly in the field of oncology and reproductive health. The company's core technologies include BDA, Toehold and QASeq. BDA technology can selectively amplify mutations in a wild-type DNA background to the extent that it can be applied to liquid tumor biopsies. Toehold technology is widely used in oncology precision medicine, pathogenic microbial detection and other applications such as the construction of molecular motors, logic gates and other nanodevices, as well as in the study of signal amplification in biosensors. QASeq is a new quantitative amplicon sequencing technology that helps developers achieve rapid development of customized NGS assays The company has cooperated with Oxford Nanopore Technologies Ltd., MD Anderson and Yale University and other enterprises. The company will develop new genetic testing products and drive registration approval for clinical products and expand its commercial teams in China and the United States. The company will also focus on nucleic acid detection underlying technology development.
Current Investors
Sequoia Capital, Pappas Capital, Yonghua Capital

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment
Website
www.carriergene.com
Verticals
HealthTech
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.